YOLFTbeta
Airway

Airway

AWM · WAR · Healthcare / Medical Instruments & Supplies

0.2335PLN-0.00 (-0.85%)

Price History

Full chart

Market Stats

Previous Close0.2355
Open0.2355
Day Range0.226 – 0.238
52-Week Range0.23 – 0.393
Volume113.68K
Market Cap28.55M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.07
Dividend Yield0.00%
Beta0.30
50-Day Avg0.2668
200-Day Avg0.2912

About

Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; B-Oral Care for intubated hospital patients; Hyper Form, a ventilation laryngeal masks and tube cuffs; and Cuff Pressure Regulator, single-patient use device that provides continuous regulation of pressure in inflatable ventilation tube cuffs. Airway Medix S.A. was founded in 2010 and is based in Warsaw, Poland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Peter Kroner
  • Employees1
  • Headquartersul. Szara 10, Warsaw, Poland, 00-420, Poland
  • Websitehttps://www.airway-medix.com

Leadership

  • Mr. Peter KronerMember of Management Board

Financials

Income Statement

Currency: PLN2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--57.00K-921.00K294.00K257.00K6.00K95.00K12.00K12.00K4.00K
Growth (%)------68.08%-12.59%-97.67%+1483.33%-87.37%0.00%-66.67%
Cost of Revenue1.36M899.00K86.00K2.83M1.00K2.12M2.14M1.76M2.84M2.53M4.60M5.76M
Gross Profit-1.36M-899.00K-29.00K-17.00K920.00K-1.82M257.00K6.00K-2.74M12.00K-4.59M-5.75M
Gross Margin---50.88%-99.89%-620.41%100.00%100.00%-2885.26%100.00%-38233.33%-143875.00%
Operating Expense-278.75K221.00K2.72M3.90M3.55M-138.00K2.52M28.19M222.00K2.78M1.47M1.48M
Operating Income-1.08M-1.12M-2.75M-3.91M-2.63M-1.69M-2.26M-28.19M-2.96M-2.77M-6.06M-7.23M
Operating Margin---4822.81%--285.45%-573.47%-879.77%-469816.65%-3118.95%-23091.67%-50483.33%-180825.00%
EBITDA-1.26M-1.22M-2.58M-4.24M-1.83M-998.00K-1.09M-16.15M-35.53M-166.00K-5.49M-7.15M
EBITDA Margin---4531.58%--199.02%-339.46%-424.90%-269100.00%-37396.84%-1383.33%-45741.67%-178725.00%
Net Income-1.83M-1.52M-2.02M635.00K-2.03M-1.36M-2.37M-7.04M-37.91M-3.28M-11.73M1.75M
Net Income Margin---3536.84%--220.85%-462.93%-923.74%-117400.00%-39909.47%-27300.00%-97791.67%43650.00%
R&D-180.00K-586.00K1.23M357.00K-12.11M----
R&D as % of Total Revenue----133.55%121.43%-201866.67%----
Interest Expense738.00K214.00K456.00K352.00K209.00K155.00K747.00K630.00K1.84M3.11M6.16M1.91M
Interest Expense % of Total Revenue--800.00%-22.69%52.72%290.66%10500.00%1942.11%25916.67%51366.67%47750.00%

Balance Sheet

Currency: PLN2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets45.05M22.83M28.98M28.50M45.65M43.77M51.48M44.50M6.21M7.36M3.82M12.28M
Total Liabilities640.66K7.68M4.68M3.25M11.65M10.94M20.83M20.59M19.56M20.57M28.14M19.46M
Total Equity44.41M15.15M24.29M25.25M34.01M32.83M30.65M23.90M-15.16M-13.21M-24.32M-8.50M
Cash390.00K123.00K445.00K3.42M1.05M707.00K2.21M29.00K1.00K655.00K2.11M127.00K
Total Debt223.00K4.88M2.53M-4.06M3.75M13.16M13.36M14.59M14.48M21.29M11.42M
Net Debt-167.00K4.75M2.09M-3.42M3.01M3.05M10.95M13.33M14.59M13.83M19.17M11.29M

Cash Flow

Currency: PLN2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.01M-998.00K-3.03M-3.69M-3.11M4.98M-2.25M-5.85M-442.00K-4.20M-7.59M-3.38M
Investing Cash Flow-2.64M-3.79M-5.46M8.80M-3.32M-6.72M-5.02M--130.00K--72.00K-237.00K
Financing Cash Flow4.30M4.52M8.49M-2.01M4.06M1.40M8.73M3.71M550.00K4.85M9.13M1.62M
Capital Expenditure2.64M4.42M5.46M5.15M3.32M6.72M5.02M0130.00K019.00K237.00K
Free Cash Flow-4.65M-5.41M-8.48M-8.84M-6.43M-1.74M-7.26M-5.85M-572.00K-4.20M-7.61M-3.62M
FCF to OCF231.54%542.38%280.28%239.74%206.75%-34.82%323.13%100.00%129.41%100.00%100.25%107.01%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------
EPS Actual-0.01-0.00-0.00-0.01-0.02-0.010.01-0.01-0.00-0.010.03-0.00-0.01-0.040.010.00-0.02-0.00-0.010.01-0.05-0.020.02-0.00-0.21-0.020.11-0.01-0.03-0.03-0.58-0.02-0.01-0.030.00-0.02-0.08-0.02-0.010.07-0.02-0.02-0.01-0.01
Surprise--------------------------------------------
Timing--------------------------------------------

Key Statistics & Ratios

Market Cap28.55M
Enterprise Value39.16M
Trailing P/E0.00
Forward P/E0.00
Price / Sales194.20
Price / Book0.99
EPS-0.07
Book Value-0.084
Revenue (TTM)147.00K
Gross Profit (TTM)-38.00K
EBITDA-14.55M
Profit Margin0.00%
Operating Margin-1974.14%
Return on Equity11.25%
Return on Assets-75.79%
Shares Outstanding115.11M
Shares Float94.88M
Beta0.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%